Insufficient scRNA-seq data for expression of LURAP1 at single-cell level.
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 501.05 | 653 / 653 | 98% | 7.04 | 592 / 605 |
brain | 99% | 201.21 | 2608 / 2642 | 97% | 3.47 | 684 / 705 |
skin | 96% | 91.32 | 1732 / 1809 | 90% | 6.79 | 427 / 472 |
adrenal gland | 99% | 152.56 | 256 / 258 | 85% | 2.51 | 196 / 230 |
kidney | 100% | 200.36 | 89 / 89 | 79% | 2.90 | 712 / 901 |
prostate | 100% | 245.54 | 245 / 245 | 67% | 1.56 | 338 / 502 |
uterus | 100% | 200.66 | 170 / 170 | 55% | 1.39 | 254 / 459 |
esophagus | 97% | 143.10 | 1400 / 1445 | 41% | 0.93 | 75 / 183 |
breast | 95% | 110.47 | 435 / 459 | 41% | 0.78 | 463 / 1118 |
bladder | 100% | 175.86 | 21 / 21 | 32% | 0.70 | 159 / 504 |
ovary | 100% | 178.36 | 180 / 180 | 30% | 0.67 | 130 / 430 |
lung | 85% | 77.59 | 493 / 578 | 39% | 0.84 | 454 / 1155 |
stomach | 95% | 103.06 | 340 / 359 | 20% | 0.33 | 57 / 286 |
blood vessel | 100% | 286.63 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 152.83 | 825 / 861 | 0% | 0 | 0 / 0 |
intestine | 82% | 106.42 | 792 / 966 | 13% | 0.21 | 71 / 527 |
adipose | 89% | 93.34 | 1073 / 1204 | 0% | 0 | 0 / 0 |
spleen | 84% | 65.16 | 202 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 81% | 4.55 | 65 / 80 |
tonsil | 0% | 0 | 0 / 0 | 64% | 1.45 | 29 / 45 |
pancreas | 3% | 1.67 | 11 / 328 | 41% | 0.66 | 73 / 178 |
muscle | 22% | 12.46 | 176 / 803 | 0% | 0 | 0 / 0 |
liver | 9% | 5.47 | 21 / 226 | 4% | 0.07 | 18 / 406 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.12 | 2 / 29 |
peripheral blood | 0% | 0.15 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001819 | Biological process | positive regulation of cytokine production |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | LURAP1 |
Protein name | Leucine rich adaptor protein 1 (Leucine repeat adapter protein 35A) |
Synonyms | LRAP35A C1orf190 LRP35A |
Description | FUNCTION: Acts as an activator of the canonical NF-kappa-B pathway and drive the production of pro-inflammatory cytokines. Promotes the antigen (Ag)-presenting and priming function of dendritic cells via the canonical NF-kappa-B pathway . In concert with MYO18A and CDC42BPA/CDC42BPB, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration. Activates CDC42BPA/CDC42BPB and targets it to actomyosin through its interaction with MYO18A, leading to MYL9/MLC2 phosphorylation and MYH9/MYH10-dependent actomyosin assembly in the lamella (By similarity). . |
Accessions | Q96LR2 ENST00000371980.4 |